Skip to main content

Table 6 Recommended analytical criteria for biomarker development

From: Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management

Validation factor

Definition [277]

Accuracy

Level of agreement between biomarker and standard measure of disease presence/outcome

Bias

Repeated biomarker measurements do not result in under/overestimation of disease activity

Repeatability

Precision of biomarker under standard "unchanged" conditions e.g. between batches

Intermediate precision

Precision of biomarker test in spite of laboratory variations e.g. time analysed, operator, equipment, calibration

Reproducibility

Precision of biomarker test between laboratories with potential variability in operators and measuring systems

LoD

The smallest amount of analyte that can be detected with a specified probability

LoQ

The smallest amount of analyte that can be quantitatively determined with acceptable precision

Linearity

Measured quantity values are directly proportional to the amount of biomarker in the experimental matrix

  1. Table adapted from Yee et al. [277]